Novartis
A Swiss pharmaceutical company focused on innovative prescription medicines in oncology, immunology, neuroscience and cardiovascular disease.
Novartis stock chart
Change the time range to compare recent moves with longer trends. Chart data is provided by TradingView.
What is Novartis?
Novartis, headquartered in Basel, Switzerland, develops, manufactures and markets prescription medicines, with a focus on oncology, immunology, neuroscience and cardiovascular disease. The company spun off its generics and biosimilars business, Sandoz, into an independent company, narrowing its focus to innovative branded medicines.
Why investors watch Novartis
Following the Sandoz separation, Novartis operates as a more focused innovative-medicine company. Investors watch its drug pipeline and approval timelines, along with the performance of its existing portfolio of branded prescription medicines.
Risks and volatility
As with other large pharmaceutical companies, Novartis faces patent expirations on key drugs, the inherent uncertainty of drug development and clinical trials, regulatory approval risk, and drug-pricing policy risk in major markets including the United States.
Long-term investing considerations
A more focused drug portfolio can mean higher dependence on fewer therapeutic areas succeeding. When testing long-term scenarios for a pharmaceutical holding, consider a range of pipeline and growth outcomes rather than a single optimistic case.
Company profile
A quick reference snapshot — sector, description and key stats, provided by TradingView.
Key financials
Revenue, margins and other reported financial data, provided by TradingView. Figures reflect company filings and can change as new reports are released.
Explore other European companies
AstraZeneca
A UK-headquartered biopharmaceutical company with a drug portfolio spanning oncology, cardiovascular,…
Explore →Novo Nordisk
A Danish pharmaceutical company known for its diabetes-care franchise and, more recently, its GLP-1 medicines…
Explore →Nestlé
The world's largest food and beverage company by revenue, with a broad portfolio of consumer brands sold…
Explore →Educational information only. This page does not recommend buying, selling or holding Novartis stock, and past performance does not indicate future results.